483 Regeneron Pharmaceuticals Mar 2010

483 Regeneron Pharmaceuticals Mar 2010

Robert Horan FDA, Chad Thompson FDA$119.00 - Available Now

FDA investigators audited the Regeneron Pharmaceuticals - Rensselaer, NY, United States facility and issued inspectional observations (via FDA 483) on 31 Mar 2010.

Product details

  • Category: Human Drugs
  • Inspection end: 31 Mar 2010
  • Location: Rensselaer, United States
  • FEI: 1000514603
Add To Cart